Sapan Shah

Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ.

Part of DAIKIN INDUSTRIES Ltd., InControl, Inc. manufactures heating, ventilation and air conditioning equipment. The company is based in Redmond, WA. The company was founded in 1990 by Kurt C. Wheeler, John M. Adams, Clifton A. Alferness, Michel E. Lussier. InControl was acquired by AirReps LLC from Boston Scientific Corp. on July 10, 2023.

NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA.

Trellis Bioscience, Inc. is discovers and develops novel human antibody therapeutics. It provides the discovery and development of therapeutic antibodies from human B cells. The firm develops the CellSpot antibody discovery platform, which enables the identification of antibodies directly from human blood. The company was founded by Lawrence Kauvar and Stote Ellsworth in 1998 and is headquartered in South San Francisco, CA.

BaroFold, Inc. develops and commercializes protein therapeutics. Its services include protein refolding, protein analytical and aggregate characterization, formulation stability and immunogenicity studies, and microbial expression. The company was founded by Matthew Seefeldt, Matthew Brewer, John F. Carpenter, Ted Randolph, Timothy C. Rodell, and Lyndal K. Hesterberg in 2009 and is headquartered in Aurora, CO.

Arbor Pharmaceuticals LLC develops pharmaceutical products, which focuses on cardiovascular, hospital and pediatric markets. It offers edarbyclor, cetylev, horizant, zenzedi, evekeo, sklice, and eryhromycin. The company was founded by Jarrett T. Disbrow and Edward J. Schutter and is headquartered in Atlanta, GA.

Industrial Origami, Inc. provides sheet material manufacturing solutions. It offers patented metal folding designs and technologies, through licenses, sub-licenses and direct supply manufacturing. The company was founded by Max W. Durney in 2002 and is headquartered in Middleburg Heights, OH.

NextWave Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder. The company was founded by Mahendra G. Shah on September 25, 2006 and is headquartered in New York, NY.

Achelios Therapeutics, Inc. operates as a bio-pharmaceutical development company. It specializes in non-steroidal anti-inflammatory drug. The company was founded by Crist J. Frangakis and is headquartered in Chaple Hill, NC.

Institutional Venture Partners (Institutional Venture Partners) is a venture capital firm founded in 1980 by Reid Dennis. The firm is headquartered in Menlo Park, California.

EJ Financial Enterprises, Inc. provides financial services. It offers advisory, mutual funds and startup investments services to the healthcare sector. The company was founded in 1990 and is headquartered in Lake Forest, IL.

Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ.

Part of Boston Scientific Corp., InFlow Dynamics, Inc. develops and manufactures custom-oriented methods of bio-compatible, minimally invasive therapy treatments. The company is based in Munich, Germany. InFlow Dynamics was acquired by Boston Scientific Corp. on February 14, 2003 for $13 million.

Part of Johnson & Johnson, Atrionix, Inc. is a company that develops a proprietary, catheter-based system for the treatment of atrial fibrillation. The company is based in Palo Alto, CA. The company was founded by James C. Peacock. Atrionix was acquired by Cordis Corp. on December 27, 2000 for $62.80 million.

Case Western Reserve University provides educational services. It offers a variety of undergraduate degree courses and graduate and professional options such as arts and sciences, dentistry, engineering, law, management, medicine, nursing, social work, and more. The firm also offers dual-degree programs. The company was founded in 1826 and is headquartered in Cleveland, OH.

Alaven Pharmaceutical LLC develops and markets prescription and non-prescription products. The company was founded on August 01, 2003 and is headquartered in Somerset, NJ.

New Haven Pharmaceuticals, Inc. develops new prescription drug products. It developes proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications. The company was founded by Harry H. Penner Jr. in 2008 and is headquartered in Branford, CT.

A-CUBE, Inc. develops novel antibodies. It utilizes silico algorithms and to discover novel druggable targets suitable for developing human therapeutic interventions, including next generation drugs for commercially proven targets. The company was founded by Nobuyuki Ota is headquartered in Belmont, CA.

Part of Shionogi & Co., Ltd., Shionogi, Inc. is a pharmaceutical company based in Florham Park, NJ. Since 1878, the company has been utilizing science to address health challenges and has discovered several novel antibiotics and medications for HIV and influenza. Shionogi conducts ongoing research into established products and new antibiotic compounds, as well as developing an investigational antiviral for COVID-19. The company is committed to pursuing discovery through partnerships, including collaboration with scientists through investigator-initiated research. Shionogi is dedicated to advancing the greater good by developing, partnering, and commercializing medicine to treat serious unmet medical needs in infectious disease and other areas of high medical need including neurology and cardiovascular disease. Nathan McCutcheon has been the CEO of the company since 2019.

Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX.

Nuvox Pharma LLC operates as biotechnology company. Its publication includes acute hypoxemic respiratory failure, hermorrrhagic shock, mechanism of action, myorcardial infarction, oncology, pharmacokinetics, stroke, and traumatic brain injury. The company was founded by Evan Unger and is headquartered in Tucson, AZ.

Epalex Corp. engages in the development of novel treatments for migraine and epilepsy. The treatment for the first time provides a way for patients with epilepsy to gain control over their seizures. The firm also develops transformational products for seizure prophylaxis in patients suffering from primary generalized epilepsies. The company was founded Randall B. Murphy and is headquartered in Palo Alto, CA.

NuvOx Therapeutics, Inc. is a clinical stage biotechnology company that develops oxygen therapeutics. The company is based in Tucson, AZ. NuvOx Therapeutics was founded by Jennifer Johnson, Evan C. Unger. Evan C. Unger has been the CEO since incorporation.